Eledon Pharmaceuticals, Inc. (ELDN)
3.20
-0.12
(-3.61%)
USD |
NASDAQ |
Aug 28, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Eledon Pharmaceuticals 30-Day Average Daily Volume : 938609.5 for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 938609.5 |
| August 27, 2026 | 931029.0 |
| August 26, 2026 | 923943.7 |
| August 25, 2026 | 937802.1 |
| August 24, 2026 | 939690.6 |
| August 21, 2026 | 932312.5 |
| August 20, 2026 | 953887.5 |
| August 19, 2026 | 982076.0 |
| August 18, 2026 | 1.017M |
| August 17, 2026 | 1.056M |
| August 14, 2026 | 1.084M |
| August 13, 2026 | 1.078M |
| August 12, 2026 | 1.111M |
| August 11, 2026 | 1.128M |
| August 10, 2026 | 1.178M |
| August 07, 2026 | 1.348M |
| August 06, 2026 | 1.361M |
| August 05, 2026 | 1.403M |
| August 04, 2026 | 1.465M |
| August 03, 2026 | 1.588M |
| July 31, 2026 | 1.622M |
| July 30, 2026 | 1.650M |
| July 29, 2026 | 1.633M |
| July 28, 2026 | 1.630M |
| July 27, 2026 | 1.623M |
| Date | Value |
|---|---|
| July 24, 2026 | 1.596M |
| July 23, 2026 | 1.578M |
| July 22, 2026 | 1.598M |
| July 21, 2026 | 1.629M |
| July 20, 2026 | 1.635M |
| July 17, 2026 | 1.630M |
| July 16, 2026 | 1.639M |
| July 15, 2026 | 1.645M |
| July 14, 2026 | 1.634M |
| July 13, 2026 | 1.626M |
| July 10, 2026 | 1.618M |
| July 09, 2026 | 1.604M |
| July 08, 2026 | 1.604M |
| July 07, 2026 | 1.554M |
| July 06, 2026 | 1.526M |
| July 02, 2026 | 1.500M |
| July 01, 2026 | 1.490M |
| June 30, 2026 | 1.474M |
| June 29, 2026 | 1.463M |
| June 26, 2026 | 1.457M |
| June 25, 2026 | 1.300M |
| June 24, 2026 | 1.300M |
| June 23, 2026 | 1.266M |
| June 22, 2026 | 1.215M |
| June 18, 2026 | 1.111M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.235M |
| Viking Therapeutics, Inc. | 1.925M |
| ACADIA Pharmaceuticals, Inc. | 1.636M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |
| Anika Therapeutics, Inc. | 117828.7 |